Inventor

BEHL BERTHOLD

DE40 patents

⚠️ This page may combine multiple inventors who share the name “BEHL BERTHOLD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BEHL BERTHOLD

BASF AG

3-substituted pyrido[4′,3′:4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use

2,3(1H,4H)quinoxalinedione

N-substituted azabicycloheptane derivatives

1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof

Substituted N-phenylpiperidines and drugs therefrom

Heterocyclic substituted imidazoloquinoxalinones, their preparation and their use

2,3(1H,4H)-quinoxalinediones

Amido-quinoxalinediones, the preparation and use thereof

N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof

Quinoxalines and drugs prepared therefrom

Imidazoloquinoxalinones for the treatment of central nervous disorders

Triazolopyrimidones their preparation and use

Triazoloquinazolines, their preparation and use

Triazoloquinazolines for the treatment of central nervous disorders

Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonist

ABBVIE DEUTSCHLAND

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Inhibitor compounds of phosphodiesterase type 10A

Inhibitor compounds of phosphodiesterase type 10A

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors

Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases

Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases

POHLKI FRAUKE

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

AMBERG WILHELM

4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy

ABBOTT LAB

Pyrrolyl quinoxalindiones their production and use as AMPA receptor antagonists

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

Pyrrolyl tetrahydroquinoxalin diones, their production and use in the treatment of diseases

LANGE UDO

Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

ABBOTT GMBH & CO KG

Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A

OCHSE MICHAEL

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

GENESTE HERVE

Inhibitor compounds of phosphodiesterase type 10A

ABBVIE INC

Radiolabeled PDE10A ligands